Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Pimasertib (AS 703026, AS703026, MSC1936369B)
print preview
bookmark
share with colleague
General Information
Company
Merck KGaA
Description
Inhibitor of MEK1 and MEK2
Molecular Target
MAP kinase kinase 1 (MAP2K1) (MEK1)
;
MAP kinase kinase 2 (MAP2K2) (MEK2)
Mechanism of Action
MEK inhibitor
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy